Multiple fusion probes

Details Multiple fusion probes Multiple fusion probes

2007-07-31

2007-07-31

Benzion, Gary (Department: 1637)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C536S024300

Reexamination Certificate

active

10119230

ABSTRACT:
A method of detecting reciprocal gene translocations by employing multiple probe sets which span the breakpoint regions and encompass regions on both sides of each breakpoint of the translocation on each chromosome involved in the translocation. Probe sets and diagnostic kits for the method are also disclosed.

REFERENCES:
patent: 4999290 (1991-03-01), Lee
patent: 5447841 (1995-09-01), Gray et al.
patent: 5538869 (1996-07-01), Siciliano
patent: 5567586 (1996-10-01), Croce
patent: 5721098 (1998-02-01), Pinkel et al.
patent: 5798262 (1998-08-01), Garini et al.
patent: 6025126 (2000-02-01), Westbrook
patent: 6280929 (2001-08-01), Gray et al.
patent: 2004/0096872 (2004-05-01), Gray et al.
patent: 0 430 402 (1999-01-01), None
Tkachuk et al., Science, vol. 250, pp. 559-562, Nov. 1990.
Dewald et al., Blood, vol. 91, No. 9, pp. 3357-3365, May 1998.
Paskulin et al., Genes, Chromosomes and Cancer, vol. 21, pp. 144-151, Feb. 1998.
Hummelen et al., Am. J. Genetics., vol. 61, pp. 651-659, 1997.
Dewald, et al, “Highly Sensitive Fluorescence In Situ Hybridization Method to Detect Double BCR/ABL Fusion and Monitor Response to Therapy in Chronic Myeloid Leukemia,” Blood, vol. 91 ( No. 9), p. 3357-3365, ( May 1, 1998).
Paskulin, et al, “Pre-Clinical Evaluation of Probes to Detect t(8;21) AML Minimal Residual Disease by Fluorescence In Situ Hybridization,” Genes, Chromosomes and Cancer, p. 144-151, (Nov. 8, 1998).
ONCOR, Inc., “1992-1993 Product Catalog,” Oncor, Inc. (Gaithersburg, MD), p. 11.
VYSIS, Inc., “1996/1997 Catalog,” Vysis, Inc. (Downers Grove, IL), p. 25 and 30.
Bigoni, et al, “Characterization of t(11;14) Translocation in Mantle Cell Lymphoma by Fluorescent in situ Hybridization,” Oncogene, p. 797-802 (1996).
Buno, et al, “A Special Fluorescent in situ Hybridization Technique to Study Peripheral Blood and Assess the Effectiveness of Interferon Therapy in Chronic Myeloid Leukemia,” BLOOD, vol. 92 ( No. 7), p. 2315-2321, (Oct. 1998).
Grand, et al, “A Two-Color BCR-ABL Probe that Greatly Reduces the False Positive and False Negative Rates for Fluorescence in situ Hybridization in Chronic Myeloid Leukemia,” Genes, Chromosomes and Cancer, p. 109-115, (1998).
Supplementary European Search Report, ( Jun. 5, 2003).
Cassel et al., “Carrier-Specific Breakpoint-Spanning DNA Probes: an Approach to Preimplantation Genetic Diagnosis in Interphase Cells,”Human Reproduction 12: 2019-2027 (Sep. 1997).
Arnoldus, E.P., et al., “Detection of the Philadelphia chromosome in interphase nuclei,”Cytogenet. Cell Genet. 54:108-111, Basel Karger (1990).
Bartram, C.R., et al., “Translocation of c-abloncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia,”Nature 306:277-280, Nature Publishing Group (1983).
Chan, L.C., et al., “A novelablprotein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia,”Nature 325:635-637, Nature Publishing Group (1987).
Clark, S.S., et al., “Expression of a DistinctiveBCR-ABLOncogene in Ph1-Positive Acute Lymphocytic Leukemia (ALL),”Science 239:775-777, American Association for the Advancement of Science (1988).
de Klein, A., et al., “A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia,”Nature 300:765-767, Nature Publishing Group (1982).
Erickson, P., et al., “Identification of Breakpoints in t(8;21) Acute Myelogenous Leukemia and Isolation of a Fusion Transcript,AML1/ETO, with Similarity to Drosphila Segmentation Gene,runt,” Blood 80:1825-1831, American Society of Hematology (1992).
Fainstein, E., et al., “A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia,”Nature 330:386-388, Nature Publishing Group (1987).
Groffen, J., et al., “Philadelphia Chromosomal Breakpoints Are Clustered within a Limited Region, bcr, on Chromosome 22,”Cell 36:93-99, Cell Press (1984).
Grosveld, G., et al., “The Chronic Myelocytic Cell Line K562 Contains a Breakpoint inbcrand Produces a Chimericbcrlc-abltranscript,”Mol. Cell. Biol. 6:607-616, American Society for Microbiology (1986).
Heisterkamp, N., et al., “Localization of the c-abloncogene adjacent to a translocation break point in chronic myelocytic leukaemia,”Nature 306:239-242, Nature Publishing Group (1983).
Heisterkamp, N., et al., “Structural organization of thebcrgene and its role in the Ph′ translocation,”Nature 315:758-761, Nature Publishing Group (1985).
Heisterkamp, N., et al., “The Human v-ablCellular Homologue,”J. Mol. Appl. Genet. 2:57-68, Raven Press (1983).
Heisterkamp, N., et al., “The first BCR gene intron contains breakpoints in Philadelphia chromosome positive leukemia,”Nucleic Acids Res. 16:10069-10081, IRL Press (1988).
Hermans, A., et al., “Unique Fusion ofbcrand c-ablGenes in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia,”Cell 51:33-40, Cell Press (1987).
Kawasaki, E.S., et al., “Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplifiedin vitro,” Proc. Natl. Acad. Sci. USA 85:5698-5702, National Academy of Sciences (1988).
Kearney, L., et al., “DNA Sequences of Chromosome 21-Specific YAC Detect the t(8;21) Breakpoint of Acute Myelogenous Leukemia,”Cancer Genet. Cytogenet. 57:109-119, Elsevier Science (1991).
Lichter, P., et al., “Rapid detection of human chromosome 21 aberrations byin situhybridization,”Proc. Natl. Acad. Sci. USA 85:9664-9668, National Academy of Sciences (1988).
Nisson, P.E., et al., “Transcriptionally Active Chimeric Gene Derived from the Fusion of the AML1 Gene and a Novel Gene on Chromosome 8 in t(8;21) Leukemic Cells,”Cancer Genet. Cytogenet. 63:81-88, Elsevier Science (1992).
Ohyashiki, K., et al., “Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia with Deleted Fusion of BCR and ABL Genes,”Jpn. J. Cancer Res. 81:35-42, Japanese Cancer Association (1990).
Pinkel, D., et al., “Fluorescencein situhybridization with human chromosome-specific libraries: Detection of trisomy 21 and translocations of chromosome 4,”Proc. Natl. Acad. Sci. USA 85:9138-9142, National Academy of Sciences (1988).
Sacchi, N., et al., “Interphase Cytogenetics of the t(8;21)(q22;q22) Associated with Acute Myelogenous Leukemia by Two-Color Fluorescence In Situ Hybridization,”Cancer Genet. Cytogenet. 79:97-103, Elsevier Science (1995).
Shtalrid, M., et al., “Analysis of Breakpoints within thebcrGene and their Correlation with the Clinical Course of Philadelphia-Positive Chronic Myelogenous Leukemia,”Blood 72:485-490, American Society of Hematology (1988).
Shtivelman, E., et al., “Alternative Splicing of RNAs Transcribed from the HumanablGene and from thebcr-ablFused Gene,”Cell 47:277-284, Cell Press (1986).
Westbrook, C.A., et al., “Long-Range Mapping of the Philadelphia Chromosome by Pulsed-Field Gel Electrophoresis,”Blood 71:697-702, Grune and Stratton, Inc. (1988).
Chase, A. et al., “Factors Influencing the False Positive and Negative Rates ofBCR-ABLFluorescenceIn SituHybridization,”Genes, Chromosomes&Cancer 18:246-253, Wiley-Liss, Inc. (Apr. 1997).
Dewald, G.W. et al., “The application of FluorescentIn SituHybridization to Detect Mbcr/abl Fusion in Varian Ph Chromosomes in CML and ALL,”Cancer Genetics and Cytogenetics 71:7-14, Elsevier Scientific Publishing Co., Inc. (1993).
Mühlmann J.et al.,“FluorescenceIn SituHybridization (FISH) on Peripheral Blood Smears for Monitoring Philadelphia Chromsome-Positive Chronic Myeloid Leukemia (CML) During Interferon Treatment: A New Strategy for Remission Assessment,”Genes, Chromsomes&Cancer 21:90-100, Wiley-Liss, Inc. (Feb. 1998).
Bernards, A., et al., “The

Affiliated with

Also associated with

Rating

Multiple fusion probes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Multiple fusion probes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multiple fusion probes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3810587